Skip to main content
Article thumbnail
Location of Repository

Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune‐suppressing and anticancer drugs: Just the tip of the iceberg?

By Adrian M. Bisceglie, Anna S. Lok, Paul Martin, Norah Terrault, Robert P. Perrillo and Jay H. Hoofnagle
Publisher: Wiley Periodicals, Inc.
Year: 2015
DOI identifier: 10.1002/hep.27609
OAI identifier:

Suggested articles

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.